A woman relaxing on a sofa under a blanket in the evening, drinking a warm nighttime drink

    Ancient + Brave

    Evaluating Sleep Outcomes in a Randomised Supplement Study

    Using Aria to deliver a remote, double-blind, placebo-controlled pilot study combining validated sleep measures, participant-reported outcomes and wearable data.

    • Supplement Research
    • Sleep
    • Randomised Pilot RCT
    • Double-Blind
    • Placebo-Controlled
    • Wearables
    • Ethics Approved

    Ethics approved by Loughborough University

    95
    Participants Recruited
    91.6%
    Study Completion Rate
    99.3%
    Task Adherence

    01

    The Challenge

    For supplement brands, understanding whether a product is making a meaningful difference requires more than customer testimonials or one-off feedback.

    Ancient + Brave wanted to evaluate the impact of a nighttime drink on sleep in women aged 40–55 experiencing self-reported sleep disturbance.

    The study needed to combine rigorous trial design with remote delivery, capturing both participants’ own experience of sleep and objective wearable-derived measures while maintaining engagement across several weeks of repeated data collection.

    02

    The Study

    The four-week, remote, randomised, double-blind, placebo-controlled pilot study involved women aged 40–55 with self-reported sleep disturbance.

    Participants were recruited from Ancient + Brave’s existing Inner Circle community. Aria provided the research infrastructure to engage that community in a structured remote human study.

    The study consists of two phases:

    2-Week Baseline Period

    Participants first completed a 14-day no-intervention baseline period, establishing their individual sleep and wellbeing measures before taking the study drink.

    2-Week Intervention Period

    Participants then completed a 14-day intervention period, with randomisation to either the nighttime drink or a matched placebo.

    The study used four parallel arms, combining product and placebo allocation with wearable and non-wearable subgroups. Participants and data analysts were blinded to treatment allocation.

    Validated PROMIS Sleep Disturbance and Sleep-Related Impairment questionnaires were collected alongside daily sleep check-ins and supplement adherence tracking. Wearable data collection applied only to participants in the wearable groups.

    The primary outcome evaluates change in subjective sleep quality from baseline to the end of the intervention compared with placebo.

    Additional outcomes include:

    • PROMIS Sleep Disturbance
    • PROMIS Sleep-Related Impairment
    • Daytime alertness and energy
    • Sleep and wellbeing
    • Evening downshift and restoration
    • Product tolerability and user experience
    • Participant adherence

    The wearable subgroup also contributes objective sleep and physiological measures including sleep duration, sleep onset latency, sleep efficiency, sleep stages, heart-rate variability and resting heart rate.

    03

    How Aria Supported the Study

    Digital Onboarding & eConsent

    Participants completed eligibility screening, digital informed consent and onboarding remotely through My Aria.

    Validated Outcomes & Daily Diaries

    PROMIS Sleep Disturbance and Sleep-Related Impairment questionnaires were delivered alongside daily sleep check-ins, symptom reporting and participant-reported wellbeing measures.

    Wearable Data Collection

    Participants in the wearable subgroup contributed objective sleep and physiological data alongside their self-reported outcomes.

    Supplement Intake & Adherence

    Daily supplement intake and repeated tolerability reporting supported adherence tracking and monitoring of participant experience during the intervention.

    Automated Reminders & Engagement

    Scheduled activities and automated reminders supported participant engagement throughout the four-week study.

    Remote Monitoring & Structured Data

    Aria Research enabled the study team to monitor progress across each study arm and collect structured research data remotely.

    04

    The Results

    The delivery metrics above show participant completion and task adherence across a remote study with repeated questionnaires, daily reporting and supplement tracking. Wearable groups also contributed wearable-derived data.

    Clinical outcome analysis is ongoing. The results presented here relate to study delivery, participant completion and task adherence.

    05

    What This Means for Supplement Brands

    An existing customer community can become a valuable research resource. With an approved protocol, ethical oversight and the right digital infrastructure, brands can conduct structured, participant-centred studies remotely, collecting validated outcomes and real-world data without requiring repeated clinic visits.

    Once a protocol and ethical approval are in place, Aria can configure remote study delivery in as little as 48 hours.

    This is a potential platform setup capability, not a guaranteed timeline for every project.

    Planning a Human Study for Your Supplement?

    Discover how Aria Health can help you conduct rigorous remote research with your existing customer community.

    Discuss Your Study